Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial.
J Transl Med
; 14: 12, 2016 Jan 13.
Article
in En
| MEDLINE
| ID: mdl-26762579
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridines
/
Biomarkers, Tumor
/
Prostatic Neoplasms, Castration-Resistant
/
Anilides
Type of study:
Clinical_trials
/
Risk_factors_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Transl Med
Year:
2016
Document type:
Article
Affiliation country:
Israel
Country of publication:
United kingdom